dBMEDx news

dBMEDx, Inc., a privately-held, wireless medical device company, announced today that it has entered into a definitive supply agreement with C. R. Bard, a subsidiary of BD (Becton, Dickinson and Company, NYSE: BDX). Under the agreement, Bard/BD will be the exclusive US distributor of the BBS RevolutionTM bladder scanner for the hospital and urology markets.

The dBMEDx BBS RevolutionTM bladder scanner was designed specifically for nurses and utilizes

dBMEDx, Inc., a privately-held, wireless medical device company, announced today that it has entered into a definitive supply agreement with Direct Supply®, the nation’s leading provider of equipment for the Senior Living market. Under the agreement, dBMEDx will integrate their proprietary bladder scanning technology into a new Direct Supply® device to create the first wireless bladder scanner optimized for use in long term care settings.

dBMEDx has developed and patente

dBMEDx was selected as the winner of the 2016 Prime Health Challenge. The company received a $75,000 cash award and was selected by two hospital groups to host a pilot clinical study of the new BBS Revolution™ bladder scanner, which was first launched by the company in 2015.

The BBS RevolutionTM is a next generation bladder scanner that offers nurses, for the first time, a fully automated bladder volume measurement solution. It delivers unparallele

dBMEDx, Inc., a privately-held, wireless medical device company, announced today that it was selected  as a finalist in the Prime Health Challenge. dBMEDx is one of six companies chosen to move onto the finals round of this year’s challenge. dBMEDx will compete on stage at the EXDO Event Center in Denver, Colorado to win a share of pilot funding provided by the Colorado Health Foundation.

dBMEDx, Inc., a privately-held, wireless medical device company, announced today that it has received the CE Mark for the BBS Revolution™, a next generation bladder scanner which offers, for the first time, fully automated bladder detection and unparalleled ease of use, speed and accuracy for the non-invasive measurement of bladder volume. This product is currently FDA cleared and is being sold to hospitals and urology offices in the US.

In addition, dBMEDx received ISO 13485 ce

dBMEDx, Inc., a privately-held, wireless medical device company, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its novel bladder scanner, the BBS RevolutionTM , a device offering unparalleled ease of use, speed and accuracy for the non-invasive measurement of bladder volume.

Bladder scanning is a critical component of a comprehensive catheter-associated urinary tract infection (CAUTI) prevention program, an area of int

dBMEDx™ , Inc., a privately-held, wireless medical device company, announces the closing of a capital raise of $1.3 million through the sale of common stock, the company’s third successful capital raise. In addition, the company announces that it has been selected to present at the Colorado BioScience Association’s 2014 BioWest Venture Showcase on September 10.

The proceeds from the round will be used to commercialize the BBS RevolutionTM device, an automated bladder

The tricorder was a multifunctional device used for sensor scanning, recording and analyzing data to help diagnose disease and collect bodily information about a patient.

That fictional object of the future is — in current day — becoming a reality, thanks to dBMEDx, a company offering a hand-held ultrasound scanner called the BBS Revolution that can be used for medical assessments.

The BBS is a user-friendly, mobile ultrasound